ABSTRACT.
INTRODUCTION

1
A large proportion of patients with systemic sclerosis (SSc) manifest a coexisting autoimmune 2 condition, including primary biliary cholangitis (PBC) [1, 2] . As immunoprecipitation (IP) is interpretation of protein-IP bands for known ANA specificities. These reference sera help in 1 determining protein-IP specificities for ANA in connective tissue diseases and are used also for SSc 2 patients as in our cohort. ACA positivity (Table 3) , and only one AMA-positive case has diffuse cutaneous SSc.
4
The pMIT3 ELISA results were in agreement with the new protein-IP profile in 13/13 (100%) sera 5 but we should note that this serology method is currently used only for research purposes. ACA- represented by AMA and ACA, respectively.
10
The diagnosis of PBC in patients with rheumatic diseases may be challenging until the clinical and antigenic subunits recognized by AMA, which has never been described before. In conclusion, we describe for the first time the protein-IP pattern of AMA and we demonstrate for 5 the first time that protein-IP can be used for AMA detection in our SSc cohort of patients. In 15% of interpretation of protein-IP, increasingly used for rare autoantibody detection in clinical practice.
Ultimately, we could also speculate that IP-AMA are earlier predictors of PBC compared to routine
TABLES.
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